SAN FRANCISCO, Sept. 23, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP, a national shareholder rights firm, notifies investors in Aardvark Therapeutics, Inc. (NASDAQ: AARD) of a pending securities class action lawsuit. Investors who purchased or acquired Aardvark common stock...
Hence then, the article about aardvark therapeutics aard investors securities fraud class action filed contact hagens berman before october 13 2026 lead plaintiff deadline was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline )
Also on site :
- Stockton high school teacher arrested in child sexual abuse material case, CHP says
- Famous Beer Secures Top Ranking in YouGov’s 2026 Alcohol Survey; The 153-Year-Old Dutch Lager Edged Baileys to Lead America’s ‘Most Considered’ Brands
- Noah Kahan, Boston, Aerosmith & More Power the New England Movement Mix: See the Playlist